A Study of JNJ-73763989 + Nucleos(t)Ide Analog in Participants Co-Infected With Hepatitis B and Hepatitis D Virus
Clinical trial NCT04535544 · COMPLETED
Trial details
- NCT number
- NCT04535544
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-17
- Primary completion
- 2023-10-19
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.